Sovaldi

Pharmalot Ed Silverman

Doctors Without Borders urges Gilead to rethink its hepatitis C strategy in Ukraine

Pharmalot Ed Silverman

As hep C sales decline, Wall Street wonders what Gilead does for its next act

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: PhRMA ups lobbying spending, hepatitis C drug report

Pharmalot Ed Silverman

Gilead pricing for Sovaldi hepatitis C drug slammed by senators